Skip to main content
Top
Published in: Internal and Emergency Medicine 6/2014

01-09-2014 | IM - ORIGINAL

Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study

Authors: Arrigo Francesco Giuseppe Cicero, Martina Rosticci, Angelo Parini, Cristina Baronio, Sergio D’Addato, Claudio Borghi

Published in: Internal and Emergency Medicine | Issue 6/2014

Login to get access

Abstract

Serum uric acid is representative for xanthine-oxidase, the key enzyme involved in the production of uric acid, which is up-regulated in the failing heart, and may play an important role in the pathophysiologic process that leads to heart failure. In our study, we investigated the relation between stroke volume, cardiac output and serum uric acid in a large sample of overall healthy pharmacologically untreated subjects. The Brisighella Heart Study included 2,939 men and women between the ages of 14–84 without prior coronary heart disease or cerebrovascular disease who were not taking antihypertensive therapy at baseline. For this study, we selected 734 adult subjects enrolled in the last Brisighella population survey not taking antihypertensive, antidiabetic, lipid-lowering and uric acid-lowering drugs, and who were also not affected by chronic heart failure or by gout. The main predictors of cardiac functionality parameters were mean arterial pressure (MAP), HR, SUA and age (all p < 0.001), while gender, BMI, LDL-cholesterol, HDL-cholesterol, triglycerides, fasting plasma glucose, creatinine, estimated glomerular filtration rate, physical activity and smoking habit were not significantly associated (all p > 0.05). In particular, there is a strong relation between estimated cardiac output and serum uric acid (B = −0.219, p < 0.001) and between stroke volume and serum uric acid (B = −3.684, p < 0.001). These observations might have an impact on future considerations about serum uric acid as an early inexpensive marker of heart function decline in the general population.
Literature
1.
go back to reference Pasalic D, Marinkovic N, Feher-Turkovic L (2012) Uric acid as one of the important factors in multifactorial disorders–facts and controversies. Biochem Med 22:63–75CrossRef Pasalic D, Marinkovic N, Feher-Turkovic L (2012) Uric acid as one of the important factors in multifactorial disorders–facts and controversies. Biochem Med 22:63–75CrossRef
4.
go back to reference Duan X, Ling F (2008) Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses 70:578–581PubMedCrossRef Duan X, Ling F (2008) Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses 70:578–581PubMedCrossRef
5.
go back to reference Shankar A, Klein R, Klein BEK, Nieto FJ (2006) The association between serum UA level and long-term incidence of hypertension: population based cohort study. J Hum Hypertens 20:937–945PubMedCrossRef Shankar A, Klein R, Klein BEK, Nieto FJ (2006) The association between serum UA level and long-term incidence of hypertension: population based cohort study. J Hum Hypertens 20:937–945PubMedCrossRef
6.
go back to reference Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum UA and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 19:1209–1215PubMedCrossRef Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum UA and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 19:1209–1215PubMedCrossRef
9.
go back to reference Cicero AFG, Dormi A, D’Addato S, Borghi C (2011) From risk factor assessment to cardiovascular disease risk and mortality modification. The first 40 years of the Brisighella Heart Study. Clin Lipidol 6:269–276CrossRef Cicero AFG, Dormi A, D’Addato S, Borghi C (2011) From risk factor assessment to cardiovascular disease risk and mortality modification. The first 40 years of the Brisighella Heart Study. Clin Lipidol 6:269–276CrossRef
10.
go back to reference Cicero AFG, D’Addato S, Santi F, Ferroni A, Borghi C, on behalf of the Brisighella Heart Study group (2012) Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. J Cardiovasc Med 13:559–564CrossRef Cicero AFG, D’Addato S, Santi F, Ferroni A, Borghi C, on behalf of the Brisighella Heart Study group (2012) Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. J Cardiovasc Med 13:559–564CrossRef
11.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes federation task force on epidemiology and prevention; National heart, lung, and blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes federation task force on epidemiology and prevention; National heart, lung, and blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef
12.
go back to reference Hickson SS, Butlin M, Broad J, Avolio AP, Wilkinson IB, McEniery CM (2009) Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res 32:1079–1085. doi:10.1038/hr.2009 PubMedCrossRef Hickson SS, Butlin M, Broad J, Avolio AP, Wilkinson IB, McEniery CM (2009) Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device. Hypertens Res 32:1079–1085. doi:10.​1038/​hr.​2009 PubMedCrossRef
13.
go back to reference Pucci G, Cheriyan J, Hubsch A, Hickson SS, Gajendragadkar PR, Watson T, O’Sullivan M, Woodcock-Smith J, Schillaci G, Wilkinson IB, McEniery CM (2013) Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J Hypertens 31:77–85. doi:10.1097/HJH.0b013e32835a8eb1 PubMedCrossRef Pucci G, Cheriyan J, Hubsch A, Hickson SS, Gajendragadkar PR, Watson T, O’Sullivan M, Woodcock-Smith J, Schillaci G, Wilkinson IB, McEniery CM (2013) Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J Hypertens 31:77–85. doi:10.​1097/​HJH.​0b013e32835a8eb1​ PubMedCrossRef
16.
go back to reference Zimmet JM, Hare JM (2006) Nitroso-redox interactions in the cardiovascular system. Circulation 114:1531–1544PubMedCrossRef Zimmet JM, Hare JM (2006) Nitroso-redox interactions in the cardiovascular system. Circulation 114:1531–1544PubMedCrossRef
17.
go back to reference Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988–998PubMedCrossRef Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988–998PubMedCrossRef
18.
22.
go back to reference Baldasseroni S, Urso R, Maggioni AP, Orso F, Fabbri G, Marchionni N, Tavazzi L, IN-CHF Investigators (2012) Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry. Nutr Metab Cardiovasc Dis 22:442–448. doi:10.1016/j.numecd.2010.08.007 PubMedCrossRef Baldasseroni S, Urso R, Maggioni AP, Orso F, Fabbri G, Marchionni N, Tavazzi L, IN-CHF Investigators (2012) Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry. Nutr Metab Cardiovasc Dis 22:442–448. doi:10.​1016/​j.​numecd.​2010.​08.​007 PubMedCrossRef
23.
go back to reference Tang ZH, Fang Z, Zeng F, Li Z, Zhou L (2013) Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure. J Endocrinol Invest [Epub ahead of print] Tang ZH, Fang Z, Zeng F, Li Z, Zhou L (2013) Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure. J Endocrinol Invest [Epub ahead of print]
24.
go back to reference Mulè G, Nardi E, Costanzo M, Mogavero M, Guarino L, Viola T, Vario MG, Cacciatore V, Andronico G, Cerasola G, Cottone S (2013) Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive women and men. Nutr Metab Cardiovasc Dis 23:715–722. doi:10.1016/j.numecd.2012.01.007 PubMedCrossRef Mulè G, Nardi E, Costanzo M, Mogavero M, Guarino L, Viola T, Vario MG, Cacciatore V, Andronico G, Cerasola G, Cottone S (2013) Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive women and men. Nutr Metab Cardiovasc Dis 23:715–722. doi:10.​1016/​j.​numecd.​2012.​01.​007 PubMedCrossRef
25.
go back to reference Savarese G, Ferri C, Trimarco B, Rosano G, Dellegrottaglie S, Losco T, Casaretti L, D’Amore C, Gambardella F, Prastaro M, Rengo G, Leosco D, Perrone-Filardi P (2013) Changes in serum uric acid levels and cardiovascular events: a meta-analysis. Nutr Metab Cardiovasc Dis 23:707–714. doi:10.1016/j.numecd.2013.03.001 PubMedCrossRef Savarese G, Ferri C, Trimarco B, Rosano G, Dellegrottaglie S, Losco T, Casaretti L, D’Amore C, Gambardella F, Prastaro M, Rengo G, Leosco D, Perrone-Filardi P (2013) Changes in serum uric acid levels and cardiovascular events: a meta-analysis. Nutr Metab Cardiovasc Dis 23:707–714. doi:10.​1016/​j.​numecd.​2013.​03.​001 PubMedCrossRef
26.
27.
go back to reference Baldus S, Müllerleile K, Chumley P, Steven D, Rudolph V, Lund GK, Staude HJ, Stork A, Köster R, Kähler J, Weiss C, Münzel T, Meinertz T, Freeman BA, Heitzer T (2006) Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy. Free Radic Biol Med 41:1282–1288PubMedCentralPubMedCrossRef Baldus S, Müllerleile K, Chumley P, Steven D, Rudolph V, Lund GK, Staude HJ, Stork A, Köster R, Kähler J, Weiss C, Münzel T, Meinertz T, Freeman BA, Heitzer T (2006) Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy. Free Radic Biol Med 41:1282–1288PubMedCentralPubMedCrossRef
Metadata
Title
Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study
Authors
Arrigo Francesco Giuseppe Cicero
Martina Rosticci
Angelo Parini
Cristina Baronio
Sergio D’Addato
Claudio Borghi
Publication date
01-09-2014
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 6/2014
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-013-1016-9

Other articles of this Issue 6/2014

Internal and Emergency Medicine 6/2014 Go to the issue

CE - MEDICAL ILLUSTRATION

A man with two syndromes

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine